Clinical Trial Update: Efficacy of Simvastatin in Alcoholic Liver Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates that simvastatin is being studied for efficacy in alcoholic liver fibrosis in Phase 2 and Phase 3, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease
• Liver Fibrosis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Anna Cruceta | Conditions: Liver Fibrosis, Alcohol Abuse | Phase 2, Phase 3 | Status: RECRUITING